Clinical Overview
The Quick Inventory of Depressive Symptomatology—Self-Report (QIDS-SR) is a 16-item self-administered assessment instrument developed by Dr. A. John Rush and colleagues to evaluate the severity of depressive symptoms in adults. This validated tool was specifically designed to correspond with the Hamilton Depression Rating Scale (HAM-D) and Montgomery-Åsberg Depression Rating Scale (MADRS) while offering the convenience of self-administration. The QIDS-SR assesses nine symptom domains that are core features of major depressive disorder including sleep disturbances, sad mood, appetite/weight changes, concentration difficulties, self-criticism, suicidal ideation, interest level, energy/fatigue, and psychomotor agitation/retardation. Each domain is evaluated through carefully constructed items that capture both the presence and severity of symptoms over the past seven days. The scale generates total scores that correlate highly with clinician-rated depression scales, making it an efficient and reliable tool for depression assessment and treatment monitoring.
Key Validation Points
- High Correlation with Clinician Ratings – Strong correlations (r = 0.81-0.86) with HAM-D and MADRS, demonstrating excellent concurrent validity
- Robust Psychometric Properties – Demonstrated excellent internal consistency (Cronbach’s alpha > 0.85) and test-retest reliability across clinical populations
- Treatment Sensitivity – Proven responsiveness to antidepressant medications and psychotherapy interventions with established minimal clinically important differences
- Factor Structure Validation – Confirmed factor structure supporting assessment of core depression symptom domains with strong psychometric properties
- Clinical Trial Validation – Extensively used in major depression clinical trials including STAR\*D study, establishing its utility as a primary outcome measure
- Cross-Cultural Validation – Successfully translated and validated in multiple languages with established measurement invariance across different populations
Primary Use Cases
- Depression Severity Assessment – Comprehensive evaluation of depression symptom severity across nine core symptom domains of major depressive disorder
- Treatment Response Monitoring – Longitudinal assessment of symptom changes following antidepressant treatment with sensitivity to detect clinical improvement
- Clinical Trial Applications – Validated outcome measure for depression research studies and pharmaceutical clinical trials requiring self-report assessment
- Clinical Practice Integration – Efficient self-report alternative to clinician-rated scales for routine depression monitoring in busy clinical settings
- Research Applications – Standardized depression measurement tool for epidemiological studies and comparative effectiveness research
Access This Scale
Choose an access option below to download the scale.
